Related references
Note: Only part of the references are listed.Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Andre Kahles et al.
CANCER CELL (2018)
Intron retention is a source o neoepitopes in cancer
Alicia C. Smart et al.
NATURE BIOTECHNOLOGY (2018)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
Samra Turajlic et al.
LANCET ONCOLOGY (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Neoantigen prediction and the need for validation
Antonella Vitiello et al.
NATURE BIOTECHNOLOGY (2017)
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Tiffany R. Hodges et al.
NEURO-ONCOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
Anna C. Filley et al.
ONCOTARGET (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
The landscape of transcription errors in eukaryotic cells
Jean-Francois Gout et al.
SCIENCE ADVANCES (2017)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang et al.
NATURE BIOTECHNOLOGY (2016)
Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation
Nuala A. O'Leary et al.
NUCLEIC ACIDS RESEARCH (2016)
Microsatellite Instability as a Biomarker for PD-1 Blockade
Jonathan C. Dudley et al.
CLINICAL CANCER RESEARCH (2016)
Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer
Jonathan W. Riess et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Classification and characterization of microsatellite instability across 18 cancer types
Ronald J. Hanse et al.
NATURE MEDICINE (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines
Spencer D. Martin et al.
PLOS ONE (2016)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes
Soren Lykke-Andersen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma
Carsten Linnemann et al.
NATURE MEDICINE (2015)
The UCSC Cancer Genomics Browser: update 2015
Mary Goldman et al.
NUCLEIC ACIDS RESEARCH (2015)
ER-associated degradation: Protein quality control and beyond
Annamaria Ruggiano et al.
JOURNAL OF CELL BIOLOGY (2014)
Proteome-wide Epitope Mapping of Antibodies Using Ultra-dense Peptide Arrays
Bjorn Forsstrom et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
Matthew D. Vesely et al.
RENAISSANCE OF CANCER IMMUNOTHERAPY (2013)
T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer
Kathrin Bauer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
Takashi Kimura et al.
CANCER PREVENTION RESEARCH (2013)
Transcriptional Regulation and Its Misregulation in Disease
Tong Ihn Lee et al.
CELL (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
The road to personalized cancer vaccines
Robert H. Vonderheide et al.
NATURE MEDICINE (2013)
Direct assessment of transcription fidelity by high-resolution RNA sequencing
Masahiko Imashimizu et al.
NUCLEIC ACIDS RESEARCH (2013)
Large-scale detection of in vivo transcription errors
Jean-Francois Gout et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Microsatellite Instability Status Is Critical to Analysis of Survival in Stage II Colon Cancer
Susie Bae et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Physical Characterization of the Immunosignaturing Effect
Phillip Stafford et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Vaccines and Other Immunological Approaches for Cancer Immunoprevention
Pier-Luigi Lollini et al.
CURRENT DRUG TARGETS (2011)
Global quantification of mammalian gene expression control
Bjoern Schwanhaeusser et al.
NATURE (2011)
Protective antigens against glanders identified by expression library immunization
Gregory C. Whitlock et al.
FRONTIERS IN MICROBIOLOGY (2011)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Fidelity at the Molecular Level: Lessons from Protein Synthesis
Hani S. Zaher et al.
CELL (2009)
The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes
Kim D. Pruitt et al.
GENOME RESEARCH (2009)
Self-Assembled Micronanoplexes for Improved Biolistic Delivery of Nucleic Acids
Sergei A. Svarovsky et al.
MOLECULAR PHARMACEUTICS (2009)
Transcriptome sequencing to detect gene fusions in cancer
Christopher A. Maher et al.
NATURE (2009)
Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer
Laura A. Vella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chimeric transcript discovery by paired-end transcriptome sequencing
Christopher A. Maher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens
Alexandre Borovkov et al.
VIROLOGY (2009)
Primer3Plus, an enhanced web interface to Primer3
Andreas Untergasser et al.
NUCLEIC ACIDS RESEARCH (2007)
Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer
DW Cramer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
High-level generation of polyclonal antibodies by genetic immunization
RS Chambers et al.
NATURE BIOTECHNOLOGY (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Share Paper
